Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study

Patients with myelodysplastic syndromes (MDS) frequently experience a significant symptom burden, which reduces health-related quality of life (HRQoL). We aimed to identify determinants of low HRQoL in patients recently diagnosed with MDS, for guiding early intervention strategies. We evaluated long...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojkov, Igor, Conrads-Frank, Annette, Rochau, Ursula, Arvandi, Marjan, Koinig, Karin A., Schomaker, Michael, Mittelman, Moshe, Fenaux, Pierre, Bowen, David, Sanz, Guillermo F., Malcovati, Luca, Langemeijer, Saskia, Germing, Ulrich, Madry, Krzysztof, Guerci-Bresler, Agnès, Culligan, Dominic J., Kotsianidis, Ioannis, Sanhes, Laurence, Mills, Juliet, Puntscher, Sibylle, Schmid, Daniela, van Marrewijk, Corine, Smith, Alexandra, Efficace, Fabio, de Witte, Theo, Stauder, Reinhard, Siebert, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275700/
https://www.ncbi.nlm.nih.gov/pubmed/36607832
http://dx.doi.org/10.1182/bloodadvances.2022008360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275700/
https://www.ncbi.nlm.nih.gov/pubmed/36607832
http://dx.doi.org/10.1182/bloodadvances.2022008360

Ejemplares similares